+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Addison's Disease Testing Market by Test Type, End User, Technology, Distribution Channel, Sample Type, Patient Age Group - Global Forecast 2025-2030- Product Image
Addison's Disease Testing Market by Test Type, End User, Technology, Distribution Channel, Sample Type, Patient Age Group - Global Forecast 2025-2030- Product Image
Sale

Addison's Disease Testing Market by Test Type, End User, Technology, Distribution Channel, Sample Type, Patient Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015134
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior executives seeking to optimize decisions in precision diagnostics will find the Addison's Disease Testing Market report an indispensable resource. The evolving landscape—marked by shifts in technology, regulation, and global supply chains—demands targeted strategies to enhance patient care and organizational resilience.

Market Snapshot: Addison's Disease Testing Market Size & Growth

The Addison's Disease Testing Market grew from USD 266.69 million in 2024 to USD 277.42 million in 2025 and is projected to advance at a CAGR of 3.95%, reaching USD 336.54 million by 2030. This expansion reflects heightened demand for precise endocrine testing driven by global adoption of advanced diagnostic technologies, increasing disease awareness, and evolving stakeholder priorities.

Scope & Segmentation of the Addison's Disease Testing Market

This report comprehensively covers market trends, technological developments, and key stakeholder dynamics, offering actionable insights across core segments and geographies.

  • Test Types: ACTH stimulation tests, cortisol measurement, dexamethasone suppression, imaging, and insulin-induced hypoglycemia tests. Each method addresses unique clinical scenarios, enabling distinction between adrenal insufficiency subtypes for both routine and specialized patient needs.
  • End Users: Ambulatory care settings, diagnostic laboratories, secondary and tertiary hospitals, research institutes, and clinicians in decentralized environments. These settings reflect the spectrum of diagnostic requirements and the integration of innovative patient care models.
  • Technologies: Lab-based automated and manual methods, as well as point-of-care solutions, supporting both centralized and real-time decentralized assessment protocols.
  • Distribution Channels: Direct sales, distributor networks, and online platforms, facilitating tailored access to products in alignment with procurement trends and care delivery models.
  • Sample Types: Blood (plasma and serum), saliva (stimulated and whole), and urine assays, ensuring comprehensive assessment across diverse clinical and logistical needs.
  • Patient Age Groups: Adult, geriatric, and pediatric populations, driving assay customization and patient-centric strategies.
  • Regional Markets: Americas (with a breakdown including major US states), Europe, Middle East & Africa (featuring Western Europe, GCC, Sub-Saharan Africa), and Asia-Pacific (highlighting North Asia, Southeast Asia, and Australia/Oceania) as key growth hubs with variable infrastructure and investment profiles.

Company profiles analyzed include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, Ortho Clinical Diagnostics, DiaSorin S.p.A., Bio-Rad Laboratories, and Fujirebio Inc.

Key Takeaways for Decision Makers

  • Laboratories, hospitals, and research institutions are rapidly shifting from traditional biochemical assays to a blended model featuring digital health integration and automation, enabling higher diagnostic accuracy and streamlined care pathways.
  • The adoption of point-of-care technologies and real-time data analytics solutions is broadening access to adrenal function testing, notably in outpatient and rural settings, providing timely and actionable clinical information.
  • Strengthened regulatory oversight, particularly around assay validation and quality management, is compelling manufacturers and providers to invest in robust systems for compliance and risk mitigation.
  • Partnerships—ranging from mergers to academic collaborations—are fueling biomarker discovery and expanding competitive capabilities, especially in markets requiring rapid, localized adaptation of technology and distribution.
  • Market growth in emerging regions is being catalyzed by local manufacturing and research partnerships, public-private initiatives, and demand for affordable diagnostics suited to varying infrastructure levels.
  • Product innovation is increasingly centered on portable assays and digital platforms designed to facilitate clinical decision-making at the bedside or in dispersed community environments.

Tariff Impact: Preparing for U.S. Policy Shifts

Forthcoming US tariffs on imported diagnostic equipment and reagents in 2025 are shaping supply chain, procurement, and cost strategies industry-wide. Laboratories and hospitals are reevaluating budgeting to account for tariff-driven price increases and potential disruptions. Manufacturers are seeking regional production solutions, renegotiating supplier contracts, and reclassifying tariff codes to mitigate operational and financial impacts. These shifts may also affect the pace of innovation by influencing research investment and development prioritization.

Methodology & Data Sources

The report’s findings are based on structured primary interviews with key opinion leaders—including endocrinologists, laboratory directors, and healthcare administrators—and complemented by secondary research from industry publications, regulatory guidelines, and validated public and proprietary databases. Cross-referencing and expert workshops ensured data triangulation and robust insight generation.

Why This Report Matters

  • Supports strategic planning for procurement, technology adoption, and market entry—enabling C-level executives to align with evolving diagnostic demands and operational realities.
  • Equips decision makers to anticipate and manage the impact of global regulatory and trade shifts, enhancing agility in supply chain and risk management.
  • Informs investment, innovation, and partnership strategies tailored to diverse regional needs and emerging competitive challenges.

Conclusion

This report provides a clear, actionable framework for navigating the complex Addison's Disease Testing Market. Stakeholders poised to leverage innovation, regulatory insight, and operational adaptability will be well prepared to meet future clinical and commercial challenges.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging point-of-care salivary cortisol assays enabling rapid Addison’s disease screening in primary care settings
5.2. Increasing adoption of liquid chromatography mass spectrometry for precise cortisol and ACTH profiling in Addison’s evaluation
5.3. Growth of multiplex immunoassays integrating cortisol and aldosterone quantification for comprehensive adrenal insufficiency assessment
5.4. Emergence of wearable biochemical sensors tracking cortisol fluctuations continuously in at risk Addison’s disease patients
5.5. Integration of AI driven predictive analytics optimizing early detection and risk stratification in Addison’s disease testing workflows
5.6. Expansion of telehealth enabled home sampling kits for cortisol stimulation and long term monitoring of adrenal function in patients
5.7. Regulatory approvals for novel synthetic short stimulation test kits streamlining adrenal insufficiency diagnostic procedures
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Addison's Disease Testing Market, by Test Type
8.1. Introduction
8.2. Acth Stimulation Test
8.3. Cortisol Measurement
8.4. Dexamethasone Suppression Test
8.5. Imaging
8.6. Insulin-Induced Hypoglycemia Test
9. Addison's Disease Testing Market, by End User
9.1. Introduction
9.2. Ambulatory Care Settings
9.3. Diagnostic Laboratories
9.4. Hospitals
9.4.1. Secondary Hospitals
9.4.2. Tertiary Hospitals
9.5. Research Institutes
10. Addison's Disease Testing Market, by Technology
10.1. Introduction
10.2. Lab-Based
10.2.1. Automated Methods
10.2.2. Manual Methods
10.3. Point-Of-Care
11. Addison's Disease Testing Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Online Sales
12. Addison's Disease Testing Market, by Sample Type
12.1. Introduction
12.2. Blood
12.2.1. Plasma
12.2.2. Serum
12.3. Saliva
12.3.1. Stimulated Saliva
12.3.2. Whole Saliva
12.4. Urine
13. Addison's Disease Testing Market, by Patient Age Group
13.1. Introduction
13.2. Adults
13.3. Geriatrics
13.4. Pediatrics
14. Americas Addison's Disease Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Addison's Disease Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Addison's Disease Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. F. Hoffmann-La Roche Ltd
17.3.2. Abbott Laboratories
17.3.3. Siemens Healthineers AG
17.3.4. Danaher Corporation
17.3.5. Thermo Fisher Scientific Inc.
17.3.6. bioMérieux SA
17.3.7. Ortho Clinical Diagnostics, Inc.
17.3.8. DiaSorin S.p.A.
17.3.9. Bio-Rad Laboratories, Inc.
17.3.10. Fujirebio Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ADDISON'S DISEASE TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ADDISON'S DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ADDISON'S DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ADDISON'S DISEASE TESTING MARKET: RESEARCHAI
FIGURE 28. ADDISON'S DISEASE TESTING MARKET: RESEARCHSTATISTICS
FIGURE 29. ADDISON'S DISEASE TESTING MARKET: RESEARCHCONTACTS
FIGURE 30. ADDISON'S DISEASE TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ADDISON'S DISEASE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ACTH STIMULATION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ACTH STIMULATION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY CORTISOL MEASUREMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY CORTISOL MEASUREMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY INSULIN-INDUCED HYPOGLYCEMIA TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY INSULIN-INDUCED HYPOGLYCEMIA TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY AUTOMATED METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY AUTOMATED METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY MANUAL METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY MANUAL METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY STIMULATED SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY STIMULATED SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY WHOLE SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY WHOLE SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY GERIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 134. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 135. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 138. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 139. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 144. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 145. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 146. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 147. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 251. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 252. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 253. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 256. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 257. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 260. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 261. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 264. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 265. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 266. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 267. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 268. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 269. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 270. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 271. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 276. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 277. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 280. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 281. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 284. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 285. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 286. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 287. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 288. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 289. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 290. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 312. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 313. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 316. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 317. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2024 (USD MILLION)
TABLE 320. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2025-2030 (USD MILLION)
TABLE 321. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 324. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 325. ITALY ADDISON'S DISEASE TESTING

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Addison's Disease Testing market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Ortho Clinical Diagnostics, Inc.
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories, Inc.
  • Fujirebio Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 277.42 Million
Forecasted Market Value ( USD ) by 2030 $ 336.54 Million
Compound Annual Growth Rate3.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Addison's Disease Treatment Market by Treatment Type (Biologics, Combination Therapies, Synthetic Hormones), Administration Route (Oral, Parenteral), End User, Distribution Channel, Age Group - Global Forecast 2025-2030 - Product Image

Addison's Disease Treatment Market by Treatment Type (Biologics, Combination Therapies, Synthetic Hormones), Administration Route (Oral, Parenteral), End User, Distribution Channel, Age Group - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Addison's Disease Global Market Report 2025 - Product Image

Addison's Disease Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Addison's Disease Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Addison's Disease Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 187 Pages
  • Global
From
Addison's Disease Therapeutics - Global Strategic Business Report - Product Image

Addison's Disease Therapeutics - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Addisons Disease Therapeutics Market 2024-2028 - Product Image

Addisons Disease Therapeutics Market 2024-2028

  • Report
  • 166 Pages
  • Global
From

About the Addison Disease Testing Market

Addison Disease Testing is a diagnostic test used to detect the presence of Addison Disease, an endocrine disorder caused by the body's inability to produce enough of the hormones cortisol and aldosterone. The test is typically performed by measuring the levels of cortisol and aldosterone in the blood, urine, or saliva. It may also include imaging tests such as CT scans or MRI scans. The Addison Disease Testing market is a growing segment of the diagnostics industry, as the prevalence of the disease is increasing. The market is driven by the increasing awareness of the disease, the availability of advanced diagnostic technologies, and the rising demand for early diagnosis and treatment. Some of the major players in the Addison Disease Testing market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Bio-Rad Laboratories, and Quest Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.